Literature DB >> 8926379

A comparative study of nosocomial and community-acquired strains of Escherichia coli causing bacteraemia in a Danish University Hospital.

B Olesen1, H J Kolmos, F Orskov, I Orskov.   

Abstract

In a previous study we found a considerably higher mortality rate in patients with nosocomial (NO) compared with community-acquired (CA) Escherichia coli bacteraemia. To establish whether this was due to host differences or to differences in the infecting bacteria, we compared 205 NO with 172 CA bacteraemic isolates of E. coli with respect to serotype, virulence factors and antimicrobial susceptibility. Overall the six most frequent O antigens were O18ac, O6, O1, O2, O15 and O75, respectively. The six most frequent capsular antigens were K1, K5, K52, K2, K7 and K34, respectively. No major differences were found regarding O-antigens, capsular antigens, production of haemolysin, P-fimbriation, serum sensitivity or antimicrobial susceptibility. Surprisingly we found 17 strains of serotype O15:K52:[H1] of both NO (eight) and CA (nine) origin with similar phenotypic characteristics to a strain causing a CA outbreak in London 1986-1987. Possibly the Danish and the English strains belong to the same clone. Our findings argue against the existence of a distinct NO flora. NO E. coli bacteraemia strains seem to originate primarily from the patients' own flora.

Entities:  

Mesh:

Year:  1995        PMID: 8926379     DOI: 10.1016/0195-6701(95)90208-2

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  20 in total

1.  Three-decade epidemiological analysis of Escherichia coli O15:K52:H1.

Authors:  Bente Olesen; Flemming Scheutz; Megan Menard; Marianne N Skov; Hans Jørn Kolmos; Michael A Kuskowski; James R Johnson
Journal:  J Clin Microbiol       Date:  2009-04-01       Impact factor: 5.948

2.  Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product.

Authors:  M Trautmann; T K Held; M Susa; M A Karajan; A Wulf; A S Cross; R Marre
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

3.  Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.

Authors:  A Sotto; C M De Boever ; P Fabbro-Peray; A Gouby; D Sirot; J Jourdan
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

4.  O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections.

Authors:  M Trautmann; M Ruhnke; T Rukavina; T K Held; A S Cross; R Marre; C Whitfield
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

5.  Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based study: healthcare-associated Gram-negative BSI.

Authors:  M N Al-Hasan; J E Eckel-Passow; L M Baddour
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-08       Impact factor: 3.267

6.  Escherichia coli serotype O15:K52:H1 as a uropathogenic clone.

Authors:  G Prats; F Navarro; B Mirelis; D Dalmau; N Margall; P Coll; A Stell; J R Johnson
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

7.  Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe.

Authors:  James R Johnson; Adam L Stell; Timothy T O'Bryan; Michael Kuskowski; Bogdan Nowicki; Candice Johnson; Joel N Maslow; Anil Kaul; Justine Kavle; Guillem Prats
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

8.  Enteroaggregative Escherichia coli O78:H10, the cause of an outbreak of urinary tract infection.

Authors:  Bente Olesen; Flemming Scheutz; Rebecca L Andersen; Megan Menard; Nadia Boisen; Brian Johnston; Dennis S Hansen; Karen A Krogfelt; James P Nataro; James R Johnson
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

9.  Analysis of the F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay.

Authors:  J R Johnson; A L Stell; F Scheutz; T T O'Bryan; T A Russo; U B Carlino; C Fasching; J Kavle; L Van Dijk; W Gaastra
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

10.  European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis.

Authors:  Simone Cagnacci; Laura Gualco; Eugenio Debbia; Gian Carlo Schito; Anna Marchese
Journal:  J Clin Microbiol       Date:  2008-06-25       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.